Skip to main content

and
  1. No Access

    Article

    Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice

    Approximately 15–40% of all cancers develop metastases in the central nervous system (CNS), yet few therapeutic options exist to treat them. Cancer therapies based on monoclonal antibodies are widely successfu...

    **g Wen, Di Wu, Meng Qin, Chaoyong Liu, Lan Wang, Duo Xu in Nature Biomedical Engineering (2019)